Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Radiation therapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides.

O'Malley JT, de Masson A, Lowry EL, Gobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA.

Clin Cancer Res. 2019 Oct 21. pii: clincanres.4147.2018. doi: 10.1158/1078-0432.CCR-18-4147. [Epub ahead of print]

PMID:
31636100
2.

Mogamulizumab Forecast: Clearer patients, with a slight chance of immune mayhem.

Larocca C, Kupper TS, LeBoeuf NR.

Clin Cancer Res. 2019 Oct 15. pii: clincanres.2742.2019. doi: 10.1158/1078-0432.CCR-19-2742. [Epub ahead of print]

PMID:
31615932
3.

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM.

Am J Surg. 2019 Sep 19. pii: S0002-9610(19)30848-7. doi: 10.1016/j.amjsurg.2019.09.017. [Epub ahead of print]

PMID:
31558307
4.

Overview of Cutaneous T-Cell Lymphomas.

Larocca CA, LeBoeuf NR.

Hematol Oncol Clin North Am. 2019 Aug;33(4):669-686. doi: 10.1016/j.hoc.2019.04.004. Epub 2019 May 23. Review.

PMID:
31229162
5.

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds.

Sivanandam V, LaRocca CJ, Chen NG, Fong Y, Warner SG.

Mol Ther Oncolytics. 2019 Apr 25;13:93-106. doi: 10.1016/j.omto.2019.04.003. eCollection 2019 Jun 28. Review.

6.

Cutaneous Malignancy.

LeBoeuf NR, Larocca C.

Hematol Oncol Clin North Am. 2019 Feb;33(1):xv-xvi. doi: 10.1016/j.hoc.2018.09.007. No abstract available.

PMID:
30497681
7.

Mycosis Fungoides and Sézary Syndrome: An Update.

Larocca C, Kupper T.

Hematol Oncol Clin North Am. 2019 Feb;33(1):103-120. doi: 10.1016/j.hoc.2018.09.001. Review.

PMID:
30497668
8.

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials.

LaRocca CJ, Warner SG.

Clin Transl Med. 2018 Nov 14;7(1):35. doi: 10.1186/s40169-018-0214-5. Review.

9.

A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer.

LaRocca CJ, Warner SG.

Biomedicines. 2018 Nov 5;6(4). pii: E104. doi: 10.3390/biomedicines6040104. Review.

10.

Academic productivity in surgical oncology: Where is the bar set for those training the next generation?

LaRocca CJ, Wong P, Eng OS, Raoof M, Warner SG, Melstrom LG.

J Surg Oncol. 2018 Sep;118(3):397-402. doi: 10.1002/jso.25143. Epub 2018 Aug 19.

11.

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer.

Salzwedel AO, Han J, LaRocca CJ, Shanley R, Yamamoto M, Davydova J.

Oncotarget. 2018 Apr 6;9(26):18041-18052. doi: 10.18632/oncotarget.24710. eCollection 2018 Apr 6.

12.

Treatment of Annular Elastolytic Giant Cell Granuloma With Topical Tretinoin.

Wagenseller A, Larocca C, Vashi NA.

J Drugs Dermatol. 2017 Jul 1;16(7):699-700.

PMID:
28697223
13.

Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.

Huang JL, LaRocca CJ, Yamamoto M.

Biomedicines. 2016 Sep 19;4(3). pii: E23. doi: 10.3390/biomedicines4030023. Review.

14.

A Case of Pseudocholinesterase Deficiency Resulting From Malnutrition.

LaRocca CJ, Beilman GJ, Birch M.

A A Case Rep. 2016 Sep 1;7(5):112-4. doi: 10.1213/XAA.0000000000000362.

PMID:
27467903
15.

Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma.

LaRocca CJ, Davydova J.

EBioMedicine. 2016 May;7:15-6. doi: 10.1016/j.ebiom.2016.05.019. Epub 2016 May 19. No abstract available.

16.

Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.

LaRocca CJ, Han J, Salzwedel AO, Davydova J, Herzberg MC, Gopalakrishnan R, Yamamoto M.

Oral Oncol. 2016 May;56:25-31. doi: 10.1016/j.oraloncology.2016.02.014. Epub 2016 Mar 18.

17.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal cancer: choosing the right candidates.

LaRocca CJ, Tuttle TM.

Expert Rev Anticancer Ther. 2015;15(8):859-61. doi: 10.1586/14737140.2015.1069187. No abstract available.

PMID:
26204905
18.

Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

LaRocca CJ, Han J, Gavrikova T, Armstrong L, Oliveira AR, Shanley R, Vickers SM, Yamamoto M, Davydova J.

Surgery. 2015 May;157(5):888-98. doi: 10.1016/j.surg.2015.01.006. Epub 2015 Feb 27.

19.

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype.

Larocca C, Cohen JR, Fernando RI, Huang B, Hamilton DH, Palena C.

Mol Cancer Ther. 2013 Sep;12(9):1805-15. doi: 10.1158/1535-7163.MCT-12-1007. Epub 2013 Jun 19.

20.

Rhinoplasty using autologous costal cartilage.

Miranda N, Larocca CG, Aponte C.

Facial Plast Surg. 2013 Jun;29(3):184-92. doi: 10.1055/s-0033-1346999. Epub 2013 Jun 12.

PMID:
23761122
21.

Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

Yan G, Eller MS, Elm C, Larocca CA, Ryu B, Panova IP, Dancy BM, Bowers EM, Meyers D, Lareau L, Cole PA, Taverna SD, Alani RM.

J Invest Dermatol. 2013 Oct;133(10):2444-2452. doi: 10.1038/jid.2013.187. Epub 2013 Apr 18.

22.

Squamous cell carcinoma as a complication of epidermolysis bullosa.

Larocca CA, Cordova AC, Price LA, Milner SM.

Am Surg. 2012 Sep;78(9):E418-9. No abstract available.

PMID:
22964184
23.

Viral vector-based therapeutic cancer vaccines.

Larocca C, Schlom J.

Cancer J. 2011 Sep-Oct;17(5):359-71. doi: 10.1097/PPO.0b013e3182325e63. Review.

24.

Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.

Larocca CA, McEvoy JW, Ellis CL, Junkins-Hopkins J, Kolb T, Baer AN, Garibaldi BT.

Clin Rheumatol. 2012 Jan;31(1):169-74. doi: 10.1007/s10067-011-1804-4. Epub 2011 Jun 28.

PMID:
21710158
25.

Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H, Larocca C, Saldanha SA, Abagyan R, Sun Y, Meyers DJ, Marmorstein R, Mahadevan LC, Alani RM, Cole PA.

Chem Biol. 2010 May 28;17(5):471-82. doi: 10.1016/j.chembiol.2010.03.006.

26.

Enhanced pneumocystis carinii activity of new primaquine analogues.

Goodwin TE, Boylan CJ, Current WL, Byrd JC, Edwards CB, Fuller DA, Green JL, Larocca CD, Raney KD, Ross AS, Tucker WA.

Bioorg Med Chem Lett. 2000 Oct 2;10(19):2205-8.

PMID:
11012030
27.

Adaptive hepatic changes in mild stenosis of the common bile duct in the rat.

Rodriguez-Garay EA, Larocca C, Pisani G, del Luján Alvarez M, Rodriguez GP.

Res Exp Med (Berl). 1999 Apr;198(6):307-23.

PMID:
10369087
28.

Medical history and risk assessment.

LaRocca CD, Jahnigen DW.

Dent Clin North Am. 1997 Oct;41(4):669-79. Review.

PMID:
9344272
29.

Synthesis and in vitro and in vivo activity of a hybrid composed of ricin B chain-barley ribosome-inactivating protein.

Ovadia M, Wiley RG, Hager C, LaRocca C, Oeltmann TN.

Arch Biochem Biophys. 1988 Jul;264(1):168-75.

PMID:
3164992
30.

Monoclonal anti-Thy 1 antibody (OX7) is axonally transported in rat nervous system.

LaRocca CD, Wiley RG.

Brain Res. 1988 May 24;449(1-2):381-5.

PMID:
2456131

Supplemental Content

Loading ...
Support Center